Frslag till bred PFAS-begrnsning Bakgrund Frslaget Konsekvenser fr miljn Tips fr pgende samrd Jenny Ivarsson, strategisk rdgivare, Kemikalieinspektionen Teknikfretagen 13 juni 2023 Varfr behver PFAS begrnsas?

FPP,EU FluoroProducts and PFAS for Europe A sector group of Cefic European Chemical Industry Council - Cefic aisbl DRAFT AGENDA FPP4EU Collaboration Platform Workshop: understanding the wide PFAS restriction Date & time: 15 June 2022; 10.00 - 15.30 (CEST) Place: hotel Thon EU, Rue de la Loi 75, 1000 Bruxelles KEYNOTE session/opening: Regulating PFAS in the EU DG ENV Valentina Bertato Safe and Sustainable Chemicals, DG Environment, PANEL 1: Expert panel (Regulators/Cefic) Introduction to Collaboration Platform Dietrich Sinnaeve, Chair of PFF4EU Collaboration Platform The wide PFAS restriction Martijn Beekman, Project Manager - PFAS REACH, RIVM Link between the firefighting foam restriction and the wide PFAS restriction Peter Simpson, Senior Scientific Officer, ECHA Decision tree Cefic Marleen Pauwels, Executive Director Halogens Industry Sector, Cefic Q&A session 10.00 -- 10.10 10.15 -- 10.25 10.30 -- 10.45 10.50 -- 11.15 11.20 -- 11.35 11.40 -- 12.00 LUNCH BREAK PANEL 2: Expert panel case studies DUs F-Gases sector and the PFAS restriction Elisa Consoli, Manager - EFCTC, Cefic (tbc) Case study on head pumps (tbc) Digital Europe Kim Jansen, Program lead - Product Safety&Environment, Canon Electronics related case study (tbc) FPG and the PFAS restriction Nicolas Robin, Director - Flouropolymers group, Plastics Europe Q&A session 13.20 - 13.35 13.40 - 13.55 14.00 - 14.15 14.20 - 14.35 14.40 - 14.55 15.00 - 15.20 Moderator and conclusions: Jonathan Crozier FluoroProducts and PFAS for Europe (FPP4EU) Rue Belliard 40, Box 15, B-1040 Brussels Tel.

PFAS in the Medical Technologies Sector Roumiana Santos, Chemicals Manager MedTech Europe 12 December 2022 Contents About the medical technologies industry Uses and role of PFAS in medical technologies Substitution - availability and assessment of alternatives Conclusions 2 About the medical technology sector 3 About MedTech Europe The European trade association for the medical technology industry including diagnostics, medical devices and digital health.

Copies to: E. 1. du Font de Nemo'rs and Company Haskell Laboratory for Toxicology and Industrial Medicine HASKELL LABORATORY REPORT NO. 58-78 MR KO Haskell -So. 11,890 Sample Ready for Testing 12/2/77 Other Codes Material Fextlle Fibe Seaford, Del 96-HOUR LC502 TO nLUEGITLL SUKFISK Procedure; The test material, in original form, was introduced into all-glass exposure vessels and di supply aCer~6o~yield the desired'concentrations in a'7.5 S. final volume.

FOR DU FONT USE ONLY AR226-2884 Copiei.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

FOR DU FONT USE ONLY AR226-2891 Copies Co E.

From: Sent: To: Cc: Subject: Attachments: HILL Malin <malin.hill@elis.com> den 8 oktober 2021 15:36 Jenny Ivarsson; Jenny Ivarsson; Mattias Carlsson Feng; Stefan Posner John Joyce; 'Take Winther'; PAULSSON-HAGLUNDAnnica; KRISTOFFERSEN WILES Lina; SUCZYNSKI Joaki m Sv: REACH PFAS restriction proposal - Meeting KEMI & El is Elis SE - Draft agenda points and questions protective clothing incl company contacts_210820.docx; Osmafin Aquablock Free produktblad.pdf; Osmafin Aquablock Free_621_SV_1.0.pdf Dear all, Here is our response from our meeting as agreed.

FOR DU PONT USE ONLY AR226-2909 W.

From: Sent: To: Subject: Attachments: N iclas Andersson < @linde.conn> den 1 september 2021 13:07 Jenny Ivarsson; @naturvardsverket.se; @baua.bund.de Linde Gas (SE) adding our view on PFAS/F-Gas survey Linde Gas SE comments on PFAS#1.pdf Hello After 1St survey and seeing reports and taking part in the webinar like the OKO/PFAS we liketo share our view on PFAS/F-Gas overviewbefore stakeholderconsultation.

AR226-3111 TRADE SECRET Study Title H-23746 and H-23747: Skin Irritation Test in Rabbits Laboratory Project ID: DuPont-1977 AUTHOR: Carol Finlay, B.A.

SPONSOR ElfAtochemSA Cours Michelet La Defense 10 92091 Paris-la-Defense CEDEX France AR226-3172 TEST SUBSTANCE ^STUIfTTITLEr SKIN SENSITIZATION TEST IN GUINEA PIGS (Maximization method ofMagnusson and Kligman) STUDY DIRECTOR Xavier Manciaux STUDY COMPLETION DATE 14 December 2000 TESTFACILITY err Centre International de Toxicologie BP 563 - 27005 Evreux - France IFM Recherche SM.C.AU wn'/u.

ee | ARAR6 -- 3234 | || | | | 416 || | | 1502-4D5u1y6:GavSaugbechSriodnyi iTnoRxsicihOneGenero Repoducion alton "TRADE SECRET Study Tie 1:24516: Subchronic Toxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations Revision No. 1 Volume 1 of5 AR226 _ 3234 DuRreovnd 3Pa8g5e "TEST GUIDELINES: U.S.

Report No.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.